Candelaria Hernández, M., López Karpovitch, X., Javier Mijangos, F., Montaño, E., Lemus Carmona, A., Guzmán Vázquez, S., & Soto Molina, H. (2017). Cost-Effectiveness of Azacitidine Compared with Low-Doses of Chemotherapy (LDC) in Myelodysplastic Syndrome (MDS). Global and Regional Health Technology Assessment, 4(1), 114–121. https://doi.org/10.33393/grhta.2017.385